For years, the clinical research industry has focused heavily on one question: How do we reach more patients?
Digital advertising, social media campaigns, patient advocacy partnerships, and online recruitment platforms have dramatically expanded researchers’ ability to connect with potential participants. Awareness of clinical trials has never been higher, and sponsors today have more recruitment channels available than ever before.
Yet despite these advances, enrollment timelines continue to challenge the industry.
The reason is becoming increasingly clear. The problem is no longer finding people who are interested in research. The challenge is finding people who actually qualify.
As protocols become more complex and eligibility criteria continue to expand, identifying patients who meet increasingly specific requirements has emerged as one of the biggest obstacles to successful recruitment. In fact, patient quality and eligibility was ranked as the second-highest recruitment challenge among pharmaceutical executives from Clinical Operations, Procurement, Patient Recruitment Leadership, and more in an externally conducted industry survey commissioned by Clariness.
This represents an important shift in how sponsors should think about recruitment. Reaching more patients alone will not solve today’s enrollment challenges. Success increasingly depends on identifying the right patients earlier in the recruitment process while minimizing unnecessary burden on both participants and research sites.
More interest doesn’t always mean more enrollment
Clinical trial recruitment has evolved considerably over the past decade.
Today’s patients are more connected than ever before. Information about research studies is easier to find, digital engagement continues to grow, and sponsors have access to sophisticated tools capable of reaching highly targeted populations.
At the same time, clinical research itself has become significantly more demanding.
Modern protocols frequently include longer lists of inclusion and exclusion criteria, multiple comorbidities, biomarker requirements, prior treatment histories and increasingly specialized patient populations. Even patients who appear to be good candidates at first glance may ultimately prove ineligible after more detailed screening.
The result is a widening disconnect between the number of interested patients entering recruitment funnels and the number who ultimately enroll.
For research sites already operating with limited time and resources, this creates an additional administrative burden. Every ineligible referral requires staff time for review, outreach, scheduling and screening, time that could otherwise be dedicated to qualified participants and ongoing study operations.
Improving recruitment today is no longer simply about generating more patient leads. It is about improving qualification throughout the entire recruitment journey.
Qualification begins long before the research site
Historically, qualification has often been viewed as something that happens during site screening.
Increasingly, however, sponsors have an opportunity to improve enrollment outcomes much earlier.
Digital recruitment strategies now allow organizations to incorporate more sophisticated pre-screening approaches before patients ever reach an investigator site. Targeted outreach based on disease characteristics, carefully designed online questionnaires with adaptive screening logic, and a patient contact center can help identify participants who are more likely to meet protocol requirements while filtering out poor matches earlier in the process.
In a recent webinar, Clariness reported that implementing a patient contact center increased the average referral-to-consent rate from 4.6% to 10.2%, representing a 2.2-fold improvement. Operationally, this translates to one consent for every 10 referrals sent to sites, compared with one consent for every 20 referrals without a patient contact center.
This benefits everyone involved.
Potential participants avoid investing time in studies for which they are unlikely to qualify. Research sites receive referrals that are better aligned with protocol requirements. Sponsors improve screening efficiency and reduce avoidable delays throughout enrollment.
Rather than viewing pre-screening as an additional step, it should increasingly be viewed as an extension of protocol feasibility and recruitment strategy itself.
The patients you’re looking for may not know they’re eligible
Qualification presents another challenge that receives far less attention: many potentially eligible participants remain invisible to traditional recruitment efforts because they have never received a formal diagnosis.
This is particularly true for conditions that are historically underdiagnosed, misunderstood or normalized by patients themselves.
Recent peer-reviewed research published in the Journal of Medical Internet Research demonstrated this challenge among women experiencing dysmenorrhea. In a real-world evidence study, researchers found that while many participants experienced symptoms consistent with the condition, only a small percentage had received a formal diagnosis despite experiencing significant disease burden.
Importantly, symptom-based digital outreach identified large numbers of women who may have otherwise remained outside the traditional healthcare system and therefore outside the reach of conventional clinical trial recruitment.
The findings illustrate an important lesson for sponsors.
Patient identification should not always begin with diagnosis codes or existing clinical databases. In many therapeutic areas, recruitment strategies that focus on symptoms and patient experiences can uncover entirely new populations of potentially eligible participants who would otherwise never enter a recruitment funnel.
As precision medicine continues to evolve, expanding the top of the funnel requires looking beyond where patients receive care and considering how they experience disease in their everyday lives.
Two ways sponsors can improve qualification
As qualification becomes a defining recruitment challenge, sponsors should consider two strategic priorities.
- Invest in real-world evidence (RWE) before launching your trial: Understanding the lived experiences (motivations and barriers) of your target patient population before recruitment begins helps to design more patient-centric studies. By listening to the patient voice through surveys and qualitative research, recruitment strategies, messaging, and study experiences can be better aligned with the realities of living with the condition.
- Invest in smarter recruitment campaigns and better patient qualification: Recruitment campaigns should be built around the characteristics that truly predict eligibility rather than broad awareness alone. The better recruitment messaging reflects protocol requirements, the higher the quality of referrals entering the funnel. Combined with digital qualification tools, adaptive pre-screening processes, and a patient contact center, sponsors can reduce unnecessary screening failures while helping sites focus on participants with the highest likelihood of enrollment.
At Clariness, we have seen firsthand how optimizing patient identification and qualification earlier in the recruitment journey can reduce burden on research sites while helping sponsors connect more efficiently with patients who are truly eligible for participation.
Looking beyond awareness
Awareness remains important. Patients cannot participate in clinical research if they never learn opportunities exist.
But awareness alone is no longer enough.
As protocols become increasingly specialized and competition for participants continues to grow, recruitment success will depend less on reaching the largest audience and more on identifying the right participants with better qualification.
The industry’s next recruitment breakthrough is unlikely to come from generating more clicks or impressions. It will come from improving qualification, strengthening patient identification, and creating recruitment strategies that deliver higher-quality participants before they ever reach the research site.
For sponsors seeking to accelerate enrollment while reducing operational burden, that shift in mindset may prove to be the most valuable recruitment strategy of all.
Author Bio
